<DOC>
	<DOCNO>NCT00417066</DOCNO>
	<brief_summary>The purpose study compare ovulation induction use flexible GnRH antagonist protocol flare GnRH agonist protocol IVF patient poor response ovarian stimulation . Our hypothesis antagonist protocol provide well IVF outcome compare flare protocol group patient .</brief_summary>
	<brief_title>Flexible GnRH Antagonist v Flare GnRH Agonist Protocol Poor Responders</brief_title>
	<detailed_description>Poor responder woman fail respond effectively usual gonadotropin stimulation protocol apply IVF cycle . It seem diminished ovarian reserve principal factor poor ovarian response . Several strategy propose management poor responder , include flare GnRH agonist regimen GnRH antagonist , present new hope group patient . Comparisons : Poor responder patient ( see inclusion criterion ) commence IVF treatment cyle receive ovarian stimulation treatment either use GnRH antagonist ( Ganirelix ) flare agonist ( Arvekap ) protocol . Primary outcome compare ongoing pregnancy rate two treatment group .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Menopause , Premature</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<mesh_term>Ganirelix</mesh_term>
	<criteria>regular menstrual cycle 1 fail IVF attempt poor response 5 few oocyte retrieve FSH &gt; 12 IU/l day 3 PCOS Normal responder</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>poor responder</keyword>
	<keyword>GnRH antagonist</keyword>
	<keyword>GnRH agonist</keyword>
	<keyword>flare</keyword>
	<keyword>short protocol</keyword>
</DOC>